Jan Theys

Jan Theys is an Associate Professor at the Faculty of Health, Medicine and Life Sciences, Maastricht University. His research focuses on the intersection of bacterial biotechnology and cancer therapy, particularly utilizing Clostridium species for targeted gene delivery and tumor-specific treatments.

• Specializes in hypoxia-targeted therapies
• Develops bacterial vectors for therapeutic protein delivery
• Investigates metabolic interactions between bacteria and tumors

His recent publications highlight innovative approaches combining radiotherapy with bacterial interventions and metabolic engineering of Clostridium strains for improved therapeutic outcomes. Key themes include tumor microenvironment manipulation, spore-based vaccination platforms, and lipidomic changes in metabolic disorders.